|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 367.00 INR | -1.56% |
|
-7.86% | -10.89% |
| 07/03 | Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 100 million in funding from Aarti Drugs Limited | CI |
| 04/02 | Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 480 | +28.76% | 1 | ||||
| 1,210 | +22.24% | 29 | ||||||
| 252.42 | +12.56% | 24 | ||||||
| 252.79 | +21.62% | 29 | ||||||
| 360.76 | +12.21% | 17 | ||||||
| 221.99 | +19.56% | 21 | ||||||
| 155.38 | +4.87% | 21 | ||||||
| 129.74 | +15.46% | 27 | ||||||
| 307.99 | +3.88% | 23 | ||||||
| 353.07 | +4.99% | 30 | ||||||
| 157.96 | +17.06% | 28 | ||||||
| 29.11 | +12.54% | 27 | ||||||
| 62.96 | +11.53% | 25 | ||||||
| 549.5 | +22.58% | 28 | ||||||
| 97.1 | +32.35% | 23 | ||||||
| 20.3 | +7.32% | 20 | ||||||
| 10,096.67 | +29.54% | 15 | ||||||
| 80.38 | +43.26% | 17 | ||||||
| 6,036.87 | +16.81% | 15 | ||||||
| Average | 1,097.63 | +17.85% | 22 | ||||||
| Weighted average by Cap. | 684.56 | +16.24% | 25 |
- Stock Market
- Equities
- 524348 Stock
- Sector Aarti Drugs Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition